Maculaser Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Maculaser General Information
Description
Developer of novel laser therapy technology designed to prevent blindness by targeting major retinal diseases. The company's technology builds electroretinography signals to control laser-induced retinal heating to treat common retinal disorders, which can be diagnosed at an early phase in a personalized and safe manner, enabling clinicians to perform previously infeasible laser therapy and control the retinal pigment epithelium layer to battle degenerative changes in the eye.
Contact Information
Website
www.maculaser.comCorporate Office
- Keilaranta 1
- 02150 Espoo
- Finland
Corporate Office
- Keilaranta 1
- 02150 Espoo
- Finland
Maculaser Timeline
Maculaser Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 28-May-2026 | Completed | Clinical Trials - General | |||
| 9. Accelerator/Incubator | 29-Sep-2023 | Completed | Clinical Trials - General | |||
| 8. Later Stage VC | 12-Dec-2022 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2022 | Completed | Clinical Trials - General | |||
| 6. Early Stage VC | 02-Sep-2021 | Completed | Clinical Trials - General | |||
| 5. Accelerator/Incubator | 08-Jun-2020 | Completed | Startup | |||
| 4. Early Stage VC | 01-Jan-2020 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
Maculaser Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Maculaser Patents
Maculaser Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4362802-A1 | A device for obtaining erg signals with related arrangement and method | Pending | 28-Jun-2021 | ||
| US-20240382139-A1 | A device for obtaining erg signals with related arrangement and method | Pending | 28-Jun-2021 | ||
| WO-2023275440-A1 | A device for obtaining erg signals with related arrangement and method | Inactive | 28-Jun-2021 | ||
| EP-4210555-A1 | An arrangement for obtaining erg signals during retinal heating and controlling retinal heating based thereon | Active | 10-Sep-2020 | ||
| EP-4210555-A4 | An arrangement for obtaining erg signals during retinal heating and controlling retinal heating based thereon | Active | 10-Sep-2020 | A61B5/398 |
Maculaser Signals
Maculaser Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| M2Care | VC-Backed Company | Minority | ||
| ZEISS Ventures | Corporate Venture Capital | Minority | ||
| Metsola Ventures | Venture Capital | Minority | ||
| Nordic Mentor Network For Entrepreneurship | Accelerator/Incubator | |||
| Innovestor | Venture Capital | Minority |
Maculaser FAQs
-
When was Maculaser founded?
Maculaser was founded in 2018.
-
Where is Maculaser headquartered?
Maculaser is headquartered in Espoo, Finland.
-
What is the size of Maculaser?
Maculaser has 5 total employees.
-
What industry is Maculaser in?
Maculaser’s primary industry is Diagnostic Equipment.
-
Is Maculaser a private or public company?
Maculaser is a Private company.
-
What is Maculaser’s current revenue?
The current revenue for Maculaser is .
-
How much funding has Maculaser raised over time?
Maculaser has raised $3.33M.
-
Who are Maculaser’s investors?
M2Care, ZEISS Ventures, Metsola Ventures, Nordic Mentor Network For Entrepreneurship, and Innovestor are 5 of 11 investors who have invested in Maculaser.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process